Copyright Reports & Markets. All rights reserved.

Global General Anesthesia Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of General Anesthesia Drugs
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global General Anesthesia Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Propofol
    • 1.3.3 Sevoflurane
    • 1.3.4 Remifentanil
    • 1.3.5 Etomidate
    • 1.3.6 Isoflurane
    • 1.3.7 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global General Anesthesia Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Intravenous Anesthetics
    • 1.4.3 Inhalational Anesthetics
  • 1.5 Global General Anesthesia Drugs Market Size & Forecast
    • 1.5.1 Global General Anesthesia Drugs Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global General Anesthesia Drugs Sales Quantity (2018-2029)
    • 1.5.3 Global General Anesthesia Drugs Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Aspen Pharma
    • 2.1.1 Aspen Pharma Details
    • 2.1.2 Aspen Pharma Major Business
    • 2.1.3 Aspen Pharma General Anesthesia Drugs Product and Services
    • 2.1.4 Aspen Pharma General Anesthesia Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Aspen Pharma Recent Developments/Updates
  • 2.2 Fresenius-Kabi
    • 2.2.1 Fresenius-Kabi Details
    • 2.2.2 Fresenius-Kabi Major Business
    • 2.2.3 Fresenius-Kabi General Anesthesia Drugs Product and Services
    • 2.2.4 Fresenius-Kabi General Anesthesia Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Fresenius-Kabi Recent Developments/Updates
  • 2.3 AbbVie
    • 2.3.1 AbbVie Details
    • 2.3.2 AbbVie Major Business
    • 2.3.3 AbbVie General Anesthesia Drugs Product and Services
    • 2.3.4 AbbVie General Anesthesia Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 AbbVie Recent Developments/Updates
  • 2.4 Baxter Healthcare
    • 2.4.1 Baxter Healthcare Details
    • 2.4.2 Baxter Healthcare Major Business
    • 2.4.3 Baxter Healthcare General Anesthesia Drugs Product and Services
    • 2.4.4 Baxter Healthcare General Anesthesia Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Baxter Healthcare Recent Developments/Updates
  • 2.5 B.Braun
    • 2.5.1 B.Braun Details
    • 2.5.2 B.Braun Major Business
    • 2.5.3 B.Braun General Anesthesia Drugs Product and Services
    • 2.5.4 B.Braun General Anesthesia Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 B.Braun Recent Developments/Updates
  • 2.6 Maruishi
    • 2.6.1 Maruishi Details
    • 2.6.2 Maruishi Major Business
    • 2.6.3 Maruishi General Anesthesia Drugs Product and Services
    • 2.6.4 Maruishi General Anesthesia Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Maruishi Recent Developments/Updates
  • 2.7 Piramal
    • 2.7.1 Piramal Details
    • 2.7.2 Piramal Major Business
    • 2.7.3 Piramal General Anesthesia Drugs Product and Services
    • 2.7.4 Piramal General Anesthesia Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Piramal Recent Developments/Updates
  • 2.8 Hikma Pharmaceuticals
    • 2.8.1 Hikma Pharmaceuticals Details
    • 2.8.2 Hikma Pharmaceuticals Major Business
    • 2.8.3 Hikma Pharmaceuticals General Anesthesia Drugs Product and Services
    • 2.8.4 Hikma Pharmaceuticals General Anesthesia Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Hikma Pharmaceuticals Recent Developments/Updates
  • 2.9 Yichang Humanwell
    • 2.9.1 Yichang Humanwell Details
    • 2.9.2 Yichang Humanwell Major Business
    • 2.9.3 Yichang Humanwell General Anesthesia Drugs Product and Services
    • 2.9.4 Yichang Humanwell General Anesthesia Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Yichang Humanwell Recent Developments/Updates
  • 2.10 Nhwa
    • 2.10.1 Nhwa Details
    • 2.10.2 Nhwa Major Business
    • 2.10.3 Nhwa General Anesthesia Drugs Product and Services
    • 2.10.4 Nhwa General Anesthesia Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Nhwa Recent Developments/Updates
  • 2.11 Hengrui
    • 2.11.1 Hengrui Details
    • 2.11.2 Hengrui Major Business
    • 2.11.3 Hengrui General Anesthesia Drugs Product and Services
    • 2.11.4 Hengrui General Anesthesia Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Hengrui Recent Developments/Updates
  • 2.12 Xi'an Libang
    • 2.12.1 Xi'an Libang Details
    • 2.12.2 Xi'an Libang Major Business
    • 2.12.3 Xi'an Libang General Anesthesia Drugs Product and Services
    • 2.12.4 Xi'an Libang General Anesthesia Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Xi'an Libang Recent Developments/Updates

3 Competitive Environment: General Anesthesia Drugs by Manufacturer

  • 3.1 Global General Anesthesia Drugs Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global General Anesthesia Drugs Revenue by Manufacturer (2018-2023)
  • 3.3 Global General Anesthesia Drugs Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of General Anesthesia Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 General Anesthesia Drugs Manufacturer Market Share in 2022
    • 3.4.2 Top 6 General Anesthesia Drugs Manufacturer Market Share in 2022
  • 3.5 General Anesthesia Drugs Market: Overall Company Footprint Analysis
    • 3.5.1 General Anesthesia Drugs Market: Region Footprint
    • 3.5.2 General Anesthesia Drugs Market: Company Product Type Footprint
    • 3.5.3 General Anesthesia Drugs Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global General Anesthesia Drugs Market Size by Region
    • 4.1.1 Global General Anesthesia Drugs Sales Quantity by Region (2018-2029)
    • 4.1.2 Global General Anesthesia Drugs Consumption Value by Region (2018-2029)
    • 4.1.3 Global General Anesthesia Drugs Average Price by Region (2018-2029)
  • 4.2 North America General Anesthesia Drugs Consumption Value (2018-2029)
  • 4.3 Europe General Anesthesia Drugs Consumption Value (2018-2029)
  • 4.4 Asia-Pacific General Anesthesia Drugs Consumption Value (2018-2029)
  • 4.5 South America General Anesthesia Drugs Consumption Value (2018-2029)
  • 4.6 Middle East and Africa General Anesthesia Drugs Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global General Anesthesia Drugs Sales Quantity by Type (2018-2029)
  • 5.2 Global General Anesthesia Drugs Consumption Value by Type (2018-2029)
  • 5.3 Global General Anesthesia Drugs Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global General Anesthesia Drugs Sales Quantity by Application (2018-2029)
  • 6.2 Global General Anesthesia Drugs Consumption Value by Application (2018-2029)
  • 6.3 Global General Anesthesia Drugs Average Price by Application (2018-2029)

7 North America

  • 7.1 North America General Anesthesia Drugs Sales Quantity by Type (2018-2029)
  • 7.2 North America General Anesthesia Drugs Sales Quantity by Application (2018-2029)
  • 7.3 North America General Anesthesia Drugs Market Size by Country
    • 7.3.1 North America General Anesthesia Drugs Sales Quantity by Country (2018-2029)
    • 7.3.2 North America General Anesthesia Drugs Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe General Anesthesia Drugs Sales Quantity by Type (2018-2029)
  • 8.2 Europe General Anesthesia Drugs Sales Quantity by Application (2018-2029)
  • 8.3 Europe General Anesthesia Drugs Market Size by Country
    • 8.3.1 Europe General Anesthesia Drugs Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe General Anesthesia Drugs Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific General Anesthesia Drugs Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific General Anesthesia Drugs Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific General Anesthesia Drugs Market Size by Region
    • 9.3.1 Asia-Pacific General Anesthesia Drugs Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific General Anesthesia Drugs Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America General Anesthesia Drugs Sales Quantity by Type (2018-2029)
  • 10.2 South America General Anesthesia Drugs Sales Quantity by Application (2018-2029)
  • 10.3 South America General Anesthesia Drugs Market Size by Country
    • 10.3.1 South America General Anesthesia Drugs Sales Quantity by Country (2018-2029)
    • 10.3.2 South America General Anesthesia Drugs Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa General Anesthesia Drugs Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa General Anesthesia Drugs Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa General Anesthesia Drugs Market Size by Country
    • 11.3.1 Middle East & Africa General Anesthesia Drugs Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa General Anesthesia Drugs Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 General Anesthesia Drugs Market Drivers
  • 12.2 General Anesthesia Drugs Market Restraints
  • 12.3 General Anesthesia Drugs Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of General Anesthesia Drugs and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of General Anesthesia Drugs
  • 13.3 General Anesthesia Drugs Production Process
  • 13.4 General Anesthesia Drugs Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 General Anesthesia Drugs Typical Distributors
  • 14.3 General Anesthesia Drugs Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global General Anesthesia Drugs market size was valued at USD 4039.3 million in 2022 and is forecast to a readjusted size of USD 5087.1 million by 2029 with a CAGR of 3.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    Global key players of general anesthesia drugs include Fresenius-Kabi, Baxter Healthcare, Aspen Pharma, etc. The top three players hold a share about 37%. Americas is the largest market, has a share about 36%, followed by Asia-Pacific and Europe, with share 29% and 28%, separately.
    General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management. General anesthesia is used in various cardiac surgeries, hip and knee replacement surgeries, cancer surgeries, and gastro-intestinal surgeries.
    This report is a detailed and comprehensive analysis for global General Anesthesia Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
    Key Features:
    Global General Anesthesia Drugs market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2018-2029
    Global General Anesthesia Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2018-2029
    Global General Anesthesia Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2018-2029
    Global General Anesthesia Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (US$/Unit), 2018-2023
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for General Anesthesia Drugs
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global General Anesthesia Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Aspen Pharma, Fresenius-Kabi, AbbVie, Baxter Healthcare and B.Braun, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
    Market Segmentation
    General Anesthesia Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Propofol
    Sevoflurane
    Remifentanil
    Etomidate
    Isoflurane
    Others
    Market segment by Application
    Intravenous Anesthetics
    Inhalational Anesthetics
    Major players covered
    Aspen Pharma
    Fresenius-Kabi
    AbbVie
    Baxter Healthcare
    B.Braun
    Maruishi
    Piramal
    Hikma Pharmaceuticals
    Yichang Humanwell
    Nhwa
    Hengrui
    Xi'an Libang
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe General Anesthesia Drugs product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of General Anesthesia Drugs, with price, sales, revenue and global market share of General Anesthesia Drugs from 2018 to 2023.
    Chapter 3, the General Anesthesia Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the General Anesthesia Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and General Anesthesia Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
    Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
    Chapter 13, the key raw materials and key suppliers, and industry chain of General Anesthesia Drugs.
    Chapter 14 and 15, to describe General Anesthesia Drugs sales channel, distributors, customers, research findings and conclusion.

    Buy now